Bausch Health has appointed Thomas J. Appio as the interim CEO of Bausch + Lomb.
Bausch Health Companies Inc has announced the appointment of Thomas J. Appio as the interim CEO of Bausch + Lomb. The company also indicated that it expects to raise its full-year 2026 guidance, signaling potential optimism for its future performance. The stock closed at C$8.36, reflecting a decline of 3.24% on the day, amid an overall negative trend of -15.73% year-to-date.
Advertisement
Bausch Health Companies Inc
BHC.TO
BHC.TO
Bausch Health Companies Inc
WealthAwesomeMarket cap
$3.13B
52W high
$11.08
52W low
$6.10
1W change
-2.34%
Beta
0.37
Analyst Price Targets
Based on analyst covering BHC · as of Sep 17, 2026
Wall Street analysts forecast BHC stock price to fall 16.2% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.01
-16.2% Upside
Current Price
C$8.36
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BHC's historical volatility
30-Day Vol
37.0%
Annualized
90-Day Vol
65.5%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$9.99
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$8.87 | C$7.81 – C$10.08 |
| 60 trading days | C$9.42 | C$7.86 – C$11.28 |
| 90 trading days | C$9.99 | C$8.01 – C$12.46 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should monitor how this leadership change impacts the company’s strategic direction and financial outlook moving forward.
Latest Trading Performance
Bausch Health's stock closed at C$8.36, down 3.24% on the day, with a trading volume of 473,050 shares.
Bull case
The new CEO could bring fresh ideas and strategies that may enhance the company’s performance moving forward.
Bear case
This leadership change might create uncertainty during a crucial time for the company.
Leadership Change at Bausch + Lomb
Advertisement
Bausch Health Companies Inc has officially appointed Thomas J. Appio as the interim CEO of Bausch + Lomb. This change in leadership comes at a pivotal time for the company, which is currently navigating a challenging market environment. The announcement coincided with a trading day where Bausch Health's stock closed at C$8.36, down 3.24%. Investors will be looking to see how Appio's leadership could potentially shift the company’s strategic focus and operational execution.
Stock Performance Overview
Following the leadership announcement, Bausch Health's stock performance reflects a broader trend of volatility. The stock has seen a decline of 3.24% in the last day and a 2.34% drop over the past week. However, the stock has gained 3.21% over the last month, indicating some recovery. The trading volume on the day of the announcement was 473,050 shares, slightly lower than the 20-day average volume of 512,843 shares, suggesting reduced trading activity as investors digest the news.
Future Guidance Expectations
In addition to the leadership change, Bausch Health has expressed intentions to raise its full-year 2026 guidance. This is a significant development, as the company has faced challenges reflected in its year-to-date performance, down 15.73%. The stock price is currently positioned at C$8.36, which is above the 200-day moving average of C$7.97, but below the 50-day moving average of C$8.64. Analysts have an average target of C$7.01, indicating a bearish outlook with an implied move to target of -16.2%. Investors will be closely monitoring how these changes affect the company’s financial outlook.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
